IMVT Immunovant Corp: Earnings per share for the last twelve months
Immunovant, Inc. (IMVT) seeks dominance in targeted immunology by developing a global blockbuster based on FcRn inhibitors. The GURU.Markets platform illustrates the rolling annual earnings per share trend, where the current level is -2.56. However, fierce competition with biotech behemoths for patients creates existential risks, and business success depends directly on clinical trial results supported by strong financing.
Analytical breakdowns and data insights for company Immunovant Corp (IMVT)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Immunovant, Inc.|IMVT - Long-Term Liabilities to Capital|Short-Term Debt to Capital immunovant.com|IMVT - Company Total Debt Obligations|Debt to Book Capitalization Ratio Immunovant Therapeutics|IMVT - Company Long-Term Liabilities|Company Short-Term Debt Immunovant|Quick Liquidity Indicator immunovant.com
- earnings and valuation multiples indicators:
IMVT - Net Profit|Expected Profit Immunovant, Inc.|IMVT - Price to Earnings Multiple|Future Price to Earnings immunovant.com|IMVT - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Immunovant Corp|IMVT - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Immunovant|IMVT - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months immunovant.com|IMVT - Earnings per share growth this year|Expected earnings per share growth for next year Immunovant, Inc.
- sales and revenue data:
Fundamental company analysis:IMVT - Immunovant Inc
Competent management of Immunovant, Inc. (IMVT) under the aegis of Roivant Sciences minimizes operational risks, making the monitoring of annual net income per share critical for assessing the efficiency of clinical phases. This metric determines the portion of final income attributable to a single share, allowing investors to balance capital growth potential against drawdown risks by analyzing changes in earnings per share over the last 12 months.
Competitor analysis
ARGX - Earnings per share for the last twelve months|BioNTech Inc. (BNTX) - Net earnings per share for the last 12 months|abivax.com (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) kiniksa.com|Earnings per share for the last twelve months Grifols Group (GRFS)|Adaptive Biotechnologies Corporation - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) CLDX (celldex.com)|Aurinia Pharma (AUPH) - Net earnings per one share for the last twelve months|BioCryst - Net earnings per share (EPS TTM)|VERA: Earnings per share for the last twelve months|DNTH: Net earnings per share (EPS TTM)|Pharvaris - Earnings per share for the trailing year|ABCL (AbCellera Bio) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Tourmaline|Net earnings per share (EPS TTM) PGEN|PHAR (pharming.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NKTR (nektar.com)|Upstream Bio (UPB) - Net earnings per one share for the last twelve months|ZBIO: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Immunome Bio|GOSS: Net earnings per share (EPS TTM)|KALV: Earnings per share for the last four quarters|SEPN (septerna.com) - Net earnings per share (EPS TTM)|Pieris Pharmaceuticals, Inc. - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Savara Inc. (SVRA)|Net earnings per share (EPS TTM) Rigel Corp (RIGL)|Earnings per share for the last twelve months AnaptysBio Inc ANAB|astriatx.com (ATXS) - Net earnings per one share for the last twelve months|enGene Bio - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RAPT|JBIO: Net earnings per share (EPS TTM)|Aclaris - Earnings per share for the trailing year|KYTX (Kyverna Therapeutics, Inc) - Net earnings per share (EPS TTM)|TLSA: Earnings per share for the trailing year|Net earnings per share for the last 12 months CABA (Cabaletta Bio)|VTYX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) THTX (Theratechnologies, Inc)|Earnings per share for the last four quarters AVTX (Avalo Therapeutics Inc.)|ELDN: Net earnings per share for the last 12 months|AGEN - Net earnings per share (EPS TTM)|Climb Bio Inc. (CLYM) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ZURA (Zura Bio)|Net earnings per share for the last 12 months ATYR|ADAG: Earnings per share for the trailing year|Net earnings per share (EPS TTM) IMA|Net earnings per share for the last four quarters Shattuck Therapeutics|Net earnings per share (EPS TTM) EQ (Equillium Inc)|Earnings per share for the last four quarters CNTB (Connect Pharma)|IMUX - Earnings per share for the last twelve months|Net earnings per share for the last four quarters atarabio.com ATRA|IFRX: Net earnings per share (EPS TTM)|XFOR (X4 Pharmaceuticals, Inc) - Earnings per share for the last twelve months|Earnings per share for the last twelve months adicetbio.com|CELU: Earnings per share for the trailing year|Earnings per share for the last twelve months INmune Bio Corporation (INMB)|Net earnings per share for the last 12 months Barinthus Biotherapeutics Corp BRNS|Earnings per share for the last twelve months Kezar Life Sciences KZR|Earnings per share for the trailing year SABS|AKTX - Earnings per share for the last twelve months|Earnings per share for the trailing year ENLV (enlivex.com)|Q32 Bio Inc. (QTTB) - Earnings per share for the last twelve months|GeoVax Labs Inc - Earnings per share for the trailing year|EDSA (Edesa Biotech Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months IBIO|Earnings per share for the last twelve months Carisma Therapeutics Inc (CARM)|Net earnings per share (EPS TTM) XTL Biopharmaceuticals Ltd (XTLB)|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics Inc.)|Net earnings per share for the last four quarters HCW Biologics Inc. (HCWB)|Aptevo Therapeutics, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters aimimmuno.com AIM|ADTX (aditxt.com) - Net earnings per share for the last 12 months|GRI (GRI Bio) - Earnings per share for the last twelve months|XRTX (XORTX Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Vyome Therapeutics|Net earnings per share (EPS TTM) REVB|Net earnings per share for the last 12 months indaptusrx.com INDP|Net earnings per share (EPS TTM) SCNI (scinai.com)|Net earnings per share (EPS TTM) CalciMedica, Inc. CALI|AFMD - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Allakos Inc ALLK|HOOK: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months IGM Biosciences Inc. (IGMS)|ITOS (iTeos Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ocean Biomedical Inc OCEA|Earnings per share for the last twelve months TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio, Inc) - Earnings per share for the trailing year
